ImmunoCellular Therapeutics Announces Issuance of Japanese Patent Covering Its Lead Antibody Product Candidate ICT-109 … (Business Wire via Yahoo! Finance)
ImmunoCellular Therapeutics Announces Issuance of Japanese Patent Covering Its Lead Antibody Product Candidate ICT-109 … (Business Wire via Yahoo! Finance)
LOS ANGELES—-ImmunoCellular Therapeutics, Ltd. , a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today the issuance of a Japanese patent relating to the company’s monoclonal antibody therapeutics.